Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Receives Average Rating of “Moderate Buy” from Analysts

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) has earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $197.50.

SLGL has been the topic of several analyst reports. HC Wainwright reiterated a “buy” rating and set a $110.00 target price on shares of Sol-Gel Technologies in a research report on Monday, July 20th. Mizuho began coverage on shares of Sol-Gel Technologies in a research report on Wednesday, June 24th. They issued an “outperform” rating and a $285.00 price target on the stock. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Sol-Gel Technologies in a research note on Tuesday, September 1st.

Sol-Gel Technologies Trading Up 9.7%

NASDAQ SLGL opened at $78.95 on Thursday. The stock’s 50 day moving average is $73.94 and its two-hundred day moving average is $74.41. The company has a market capitalization of $221.85 million, a price-to-earnings ratio of -14.00 and a beta of 1.14. Sol-Gel Technologies has a 1-year low of $28.81 and a 1-year high of $97.97.

Sol-Gel Technologies (NASDAQ:SLGL) last released its quarterly earnings data on Friday, August 21st. The company reported ($1.13) earnings per share for the quarter, beating the consensus estimate of ($2.36) by $1.23. Sol-Gel Technologies had a negative return on equity of 44.05% and a negative net margin of 910.14%.The company had revenue of $0.59 million for the quarter, compared to analyst estimates of $0.07 million. On average, analysts predict that Sol-Gel Technologies will post -4.95 earnings per share for the current year.

Insider Activity

In other Sol-Gel Technologies news, major shareholder Opaleye Management Inc. bought 35,113 shares of Sol-Gel Technologies stock in a transaction dated Friday, August 28th. The shares were acquired at an average cost of $69.32 per share, with a total value of $2,434,033.16. Following the acquisition, the insider directly owned 520,000 shares of the company’s stock, valued at $36,046,400. The trade was a 7.24% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders have purchased a total of 53,959 shares of company stock valued at $3,723,781 in the last three months. Insiders own 66.51% of the company’s stock.

Institutional Investors Weigh In On Sol-Gel Technologies

An institutional investor recently bought a new stake in Sol-Gel Technologies stock. Navellier & Associates Inc. acquired a new position in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 5,785 shares of the company’s stock, valued at approximately $429,000. Navellier & Associates Inc. owned about 0.21% of Sol-Gel Technologies at the end of the most recent reporting period. 26.18% of the stock is owned by institutional investors and hedge funds.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is an Israeli specialty pharmaceutical company focused on developing and commercializing topical dermatological treatments. The company uses proprietary silica-based microsponge technology designed to encapsulate and gradually release active pharmaceutical ingredients in the skin.

Its marketed products include TWYNEO, a topical cream combining tretinoin and benzoyl peroxide for the treatment of acne vulgaris, and EPSOLAY, a topical benzoyl peroxide cream for the treatment of inflammatory lesions associated with rosacea.